Forward genetic screening with CRISPR-Cas9 has created remarkable new opportunities for biological discovery. The power of complete gene knockout in a pooled screening platform has delivered novel target ID, tackled complex mechanism of action, and driven the design of efficient and economical patient stratification for clinical studies. Using transcriptional regulation with catalytically-dead Cas9 (dCas9), both loss-of-function studies (CRISPR interference, CRISPRi) and gain-of-function studies (CRISPR activation, or CRISPRa) are now possible at a genome-wide level. Horizon Discovery is leveraging these technologies to address novel research questions and deliver insights into essential gene function, hypomorphic expression, and gene dominance. In this webinar we will introduce these new powerful tools and share our screening datasets. Attendees can interact with our expert speaker during the live webinar, asking questions and discussing their experiences.
Topics to be covered:
- Introduction to CRISPRi...
Meet the Speaker:
Benedict Cross, PhD
Functional Genomic Screening Lead